Abstracts tagged "myositis and sarcoidosis"

Abstract Number: 2289 • 2018 ACR/ARHP Annual Meeting
Granulomatous Myositis: Heterogeneity and Response to Treatment
Yannick Dieudonné¹, Yves Allenbach², Olivier Benveniste³, Sarah Leonard-louis⁴, Baptiste Hervier², Kuberaka Mariampillai³, Beatrice Lannes⁵, Daniel Wendling⁶, Christan Von Frenckell⁷, Nicolas Poursac⁸, Emmanuel Mortier⁹, Christian Lavigne¹⁰, Olivier Hinschberger¹¹, Julie Magnant¹², Bernard Geny¹³, Jean Sibilia¹⁴ and Alain Meyer¹⁵, ¹Département d’Immunologie Clinique et Médecine Interne, Centre de Référence des Maladies Auto-immunes Rares, Hôpitaux Universitaires de Strasbourg, STRASBOURG, France, ²Department of Internal Medicine and Clinical Immunology and Inflammation-Immunopathology-Biotherapy Department (I2B), Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, East Paris Neuromuscular Diseases Reference Center, Paris, France, ³Département de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Neuro-Musculaires Paris Est, Assistance Publique – Hôpitaux de Paris (AP-HP), Hôpital Universitaire Pitié-Salpêtrière, Paris, France, ⁴Département de Neuropathologie, Centre de Référence des Maladies Neuro-Musculaires Paris Est, Assistance Publique – Hôpitaux de Paris (AP-HP), Hôpital Universitaire Pitié-Salpêtrière, Paris, France, ⁵Département de Pathologie, Hôpitaux Universitaires de Strasbourg, STRASBOURG, France, ⁶Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, ⁷Département de Rhumatologie, Hôpital Universitaire Sart-Tilman, Liège, Belgium, ⁸9Departement de Rhumatologie, Hôpital Universitaire de Bordeaux, Bordeaux, France, ⁹Departement de Médicine Interne, Hôpital Universitaire Louis Mourier, Colombes, France, ¹⁰Departement de Médicine Interne et Maladies Vasculaires, Hopital Universitaire d'Angers, Angers, France, ¹¹Departement de Médicine Interne, Hôpital Emile Muller, Mulhouse, France, ¹²Departement de Médicine Interne, Hôpital Universitaire de Tours, Tours, France, ¹³Institut de Physiologie EA 3072, Service de Physiologie et d’Explorations Fonctionnelles, Hôpitaux Universitaires de Strasbourg, Strasbourg, France, ¹⁴Département de Rhumatologie, Centre de Référence des Maladies Auto-immunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France, ¹⁵15Département de Rhumatologie, Centre de Référence des Maladies Auto-immunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Background/Purpose: Granuloma in the muscle can be found in patients with myopathy. This finding has alternatively been interpreted as either sarcoid myopathy or other myositis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].